CTRI/2011/07/001919尚未招募未知
Intravitreal Pegaptanib for treatment of Choroidal Neovascularisation secoundary to Pathologic Myopia-A Pilot Study - INJECT
VPrasad Eye Institute0 个研究点目标入组 20 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Should be willing to participate in the trial.
- •2.Age less than 55 years.
- •3.Best corrected visual acuity (BCVA) score of at least 5 letters (20/200), as assessed by ETDRS chart.
- •4.Myopia of greater than or equal to 6 Diopters.
- •5.Fluorescein angiographic documentation of CNV.
排除标准
- •1.Ocular causes, or other ocular disorders leading to vision loss.
- •2.Maculopathy not related to pathologic myopia.
- •3.Pregnancy, lactation.
- •4.Not willing to provide an informed consent.
- •5.History of previous macular laser including PDT.
- •6.Other forms of therapy including intravitreal injections.
- •7.History of intraocular surgery in the past 3 months.
- •8.Anticipated cataract surgery in the next 6 months.
- •9.Any active infection or inflammation in the eye.
- •10.Cases where good quality imaging is not possible, either due to hazy media or extremely high myopia.
- •11.Patients with uncontrolled glaucoma, with IOP 21mm Hg on 2 or more medications.
- •12.Patients with subfoveal scar or significant subretinal haemorrhage occupying more than 50% of lesion size.
- •13.Eyes with previous retinal detachment.
研究者
相似试验
进行中（未招募）
不适用
Treatment of a chorioretinal disease characterized by alterations in the elastic lamina of the Bruch's membrane, and which typically manifest themselves as streaks radial departure from the optic nerveEUCTR2014-000986-30-ITIRCCS Ospedale San Raffaele U.O. Oculistica
进行中（未招募）
1 期
Intravitreal Aflibercept (Eylea®) for therapy of choroidal neovascularization and fibrovascular proliferation in patients with Pseudoxanthoma elasticumChoroidal neovascularizations and fibrovascular proliferations in patients with Pseudoxanthoma elasticumMedDRA version: 20.0Level: PTClassification code 10037150Term: Pseudoxanthoma elasticumSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2014-005263-33-DEMedizinische Fakultät der Universität Bonn15
撤回
不适用
Intravitreal Pegaptanib in Treatment of Choroidal Neovascularisation Secondary to Pathologic MyopiaMyopic Choroidal Neovascular MembraneNCT01218230L.V. Prasad Eye Institute
尚未招募
3 期
To investigate the role of Intravitreal Aflibercept (Eylea) in the treatment of patients whose wet Age related Macular degeneration is not adequately controlled with conventional anti VEGF (intravitreal Avastin or Lucentis) treatment.ACTRN12613001020774Greenlane Clinical Centre Auckland District Health Board50
进行中（未招募）
1 期
Re-treatment with intravitreal application of ranibizumab guided by morphological macular changes documented by optical coherence tomography (OCT) in patients with macular edema due to branch retinal vein occlusiomacular edema secondary to branch retinal vein occlusion (BRVO)MedDRA version: 18.1Level: LLTClassification code 10054467Term: Macular edemaSystem Organ Class: 100000004853MedDRA version: 18.1Level: LLTClassification code 10038906Term: Retinal vein branch occlusionSystem Organ Class: 100000004853EUCTR2012-005439-10-DEniversity of Leipzig Ritterstr. 26, 04109 Leipzig18